Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Eisai
Eisai
Eisai and Biogen facing delay to Leqembi in Europe
Pharmaphorum
Mon, 03/25/24 - 11:22 am
Eisai
Biogen
Leqembi
Europe
Alzheimer's disease
Eisai backs Leqembi’s Japan rollout with insurance policy
Pharmaphorum
Thu, 03/21/24 - 11:19 am
Eisai
Lifenet
insurance
Leqembi
dementia
FDA guidelines consider amyloid reduction 'reasonably likely' to predict Alzheimer's benefit
Fierce Biotech
Tue, 03/12/24 - 11:34 am
Biogen
Eisai
Aduhelm
FDA
Alzheimer's disease
amyloid
Eli Lilly
donanemab
Tau, anti-inflammation and orals form Biogen's future Alzheimer's pipeline
Fierce Biotech
Thu, 03/7/24 - 11:38 am
Biogen
Alzheimer's disease
anti-tau antibodies
anti-inflammatory
Eisai
Leqembi
Japan's Eisai says US introduction of Alzheimer's drug Leqembi slower than expected
Reuters
Thu, 03/7/24 - 11:07 am
Eisai
Leqembi
drug launches
Alzheimer's disease
Eisai, Biogen likely to miss early launch goal for Alzheimer's drug Leqembi
Fierce Pharma
Wed, 02/7/24 - 11:33 am
Eisai
Biogen
FDA
Medicare
Leqembi
Alzheimer's disease
EU regulators to consult advisers in review of Eisai Alzheimer’s drug
BioPharma Dive
Thu, 01/11/24 - 08:40 pm
Eisai
Leqembi
Europe
Alzheimer's disease
Eisai files biliary tract cancer drug tasurgratinib in Japan
Pharmaphorum
Mon, 12/18/23 - 10:14 am
Eisai
Japan
tasurgratinib
biliary tract cancer
Merck-Eisai's endometrial cancer therapy combo fails first-line treatment trial
Reuters
Fri, 12/8/23 - 09:59 am
Merck
Eisai
4523.T
clinical trials
endometrial cancer
Keytruda
Lenvima
Eisai expects Alzheimer's drug to rake in revenue of $66.5 million by March
Reuters
Tue, 11/7/23 - 09:57 am
Eisai
Leqembi
Alzheimer's disease
Eisai says new data could support more convenient form of Alzheimer’s drug Leqembi
BioPharma Dive
Wed, 10/25/23 - 10:42 pm
Eisai
Biogen
Leqembi
Alzheimer's disease
As 'harvest time' arrives for Alzheimer's, neuroscientist reflects on next steps for drug development
Fierce Biotech
Mon, 10/16/23 - 10:12 am
Alzheimer's disease
Biogen
Eisai
Eli Lilly
Leqembi
donanemab
Biogen's Aduhelm headache returns as appeals court revives part of investor lawsuit
Fierce Pharma
Thu, 10/12/23 - 05:18 pm
Biogen
Aduhelm
legal
Eisai
Alzheimer's disease
6 Drugs Approved Despite Failed Trials or Minimal Data
BioSpace
Mon, 10/9/23 - 11:10 am
Ipsen
Sohonos
Sarepta Therapeutics
Elevidys
Biogen
Qalsody
Eisai
Aduhelm
Jazz Pharma
PharmaMar
Zepzelca
Acadia Pharma
Nuplazid
Japan approves Alzheimer's treatment Leqembi by Eisai and Biogen
Reuters
Tue, 09/26/23 - 10:23 am
Biogen
Eisai
Japan
Leqembi
Alzheimer's disease
Merck and Eisai's Keytruda-Lenvima combo chalks up 2 more losses, this time in non-small cell lung cancer
Fierce Pharma
Fri, 09/22/23 - 11:46 am
Merck
Eisai
Keytruda
Lenvima
melanoma
colorectal cancer
non-small cell lung cancer
Eisai launches digital dementia specialist company
Pharmaphorum
Tue, 09/12/23 - 12:06 pm
Eisai
digital health
dementia
Theoria Technologies
The Alzheimer’s Treatment Landscape: Leqembi vs. Donanemab
BioSpace
Mon, 09/11/23 - 12:34 pm
Alzheimer's disease
Eli Lilly
Biogen
Eisai
Leqembi
donanemab
Merck, Eisai Drop Phase III Keytruda-Lenvima Trial for Head and Neck Cancer
BioSpace
Sun, 08/27/23 - 04:40 pm
Merck
Eisai
Keytruda
Lenvima
clinical trials
head and neck cancer
New Alzheimer’s drug raises hopes — along with questions
Medical Marketing and Media
Mon, 08/14/23 - 06:54 pm
FDA
Alzheimer's disease
Eisai
Biogen
Leqembi
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »